Health Canada Approves First Vaccine to Help Prevent Cervical Cancer
July 19, 2006
On Tuesday, Health Canada gave its approval to the first vaccine to prevent the STD human papillomavirus (HPV). The approval of Gardasil, to be sold in Canada by Merck Frosst Canada, follows similar action last month by the U.S. Food and Drug Administration. Like FDA, Health Canada approved Gardasil determine Gardasil's effectiveness in women beyond that age and in men. Gardasil protects against the four strains of HPV that cause about 70 percent of cervical cancer cases, plus genital warts and cancers of the vulva and vagina. The Canadian Cancer Society hailed Health Canada's approval of Gardasil, saying the vaccine could prevent hundreds of cervical cancer cases in the country each year.
07.18.06; Sheryl Ubelacker
California: San Luis Obispo County Supervisors OK Needle Exchange Programs to Help Reduce Spread of Diseases
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.